Shinpoong will open cephalosporin plant at Osung complex

Published: 2012-03-26 06:56:00

Updated: 2012-03-26 06:56:00

Shinpoong Pharmaceutical Co. will complete its EU-GMP plant next month for production of cephalosporin antibiotics in the form of bulks and finished products at Osung complex to make inroads to the European market to expand its presence through the ongoing licensing-out negotiations.

The compa...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK